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Cellular non-coding RNA (ncRNA) transcription and
regulation has only recently been systematically investi-
gated. Studies have demonstrated abundant transcription
of a set of ncRNAs preferentially within tumors as
opposed to normal tissue. In some cases these tumor-
associated ncRNAs also associate with inflammatory
cytokine production suggesting potential immunostimu-
latory qualities. Using a novel approach from statistical
physics we quantify global transcriptome-wide motif
usage for the first time in human and murine ncRNAs
determining that most have motif usage consistent with
the coding genome. However an outlier subset of tumor-
associated ncRNAs typically of recent evolutionary origin
has motif usage more associated with pathogen RNA.
Here we show that a human repeat enhances immunosti-
mulatory motifs CpG dinucleotides in AU-rich contexts
which most of the human genome and human adapted
viruses have evolved to avoid. We demonstrate that a key
subset of these ncRNA function as immunostimulatory
“self-agonists” and directly activate cells of the mononuc-
lear phagocytic system to produce pro-inflammatory
cytokines. These ncRNAs arise from endogenous repeti-
tive elements that are normally silenced, yet are often
very highly expressed in cancers. We conclude that the
innate response in tumors partially originates from direct
interaction of immunogenic ncRNAs expressed in cancer
cells with innate pattern recognition receptors and
thereby assign a new danger-associated function to a set
of dark matter repetitive elements, potentially reconciling
several observations concerning the role of ncRNA
expression in cancers. We consider the possible roles
they may play in the tumor microenvironment.
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